Click on headlines below to download research
Checkit made good progress during FY22 with its strategy to transition to a pure SaaS business. Annualised recurring revenue (ARR) grew 44% y-o-y, helped…
Checkit’s FY22 trading update confirmed it closed the year broadly in line with our revenue forecasts and, due to several contracts signed close…
Checkit has signed a three-year subscription contract with Biomat USA, a subsidiary of plasma and infusion medicines specialist Grifols, to provide its…
Checkit’s SaaS platform is designed to bring visibility to the operations of businesses with dispersed, deskless workforces. Checkit is focused on…
Checkit has expanded its existing relationship with BP by rolling out its intelligent operations platform for workflow management and automated monitoring…